GGrantIndex
← Leaderboards

Robert F. Schwabe

Columbia University Health Sciences

$23,538,022
Attributed
$30,482,683
Total exposure
19
Grants
17
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$35,324,571 · 20

By mechanism

R01$21,986,498 · 11
U01$6,076,830 · 2
P30$5,825,775 · 3
U54$956,943 · 2
R21$448,525 · 1
R13$30,000 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Liver

Research focus

LiverCellsLinkPathway InteractionsSignal TransductionFibrosisAffectInflammationLiver DiseasesMediatingBaseInjuryReceptorChronicPreventionLiver FibrosisMediator Of Activation ProteinPrimary Carcinoma Of The Liver CellsHepaticHepatocyteExtracellular MatrixGrowthResponseTumor

Grant awards (76)

The Columbia University Digestive and Liver Disease Research Center$1,188,753
P30 · FY2025 · DK · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$1,152,768
U01 · FY2025 · CA
Understanding and Targeting Transcriptional Master Regulators in Hepatocellular Carcinoma$687,679
R01 · FY2025 · CA · contact PI
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC$500,089
R01 · FY2025 · CA · contact PI
The Administrative Core$245,836
P30 · FY2025 · DK · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$110,000
U01 · FY2025 · CA
The Columbia University Digestive and Liver Disease Research Center$1,204,298
P30 · FY2024 · DK · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$776,779
U01 · FY2024 · CA
Protective and fibrosis-independent functions of hepatic stellate cells$499,972
R01 · FY2024 · DK · contact PI
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC$481,473
R01 · FY2024 · CA · contact PI
The Administrative Core$246,248
P30 · FY2024 · DK · contact PI
The Columbia University Digestive and Liver Disease Research Center$1,218,942
P30 · FY2023 · DK · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$955,015
U01 · FY2023 · CA
Protective and fibrosis-independent functions of hepatic stellate cells$517,953
R01 · FY2023 · DK · contact PI
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC$501,946
R01 · FY2023 · CA · contact PI
The Administrative Core$246,247
P30 · FY2023 · DK · contact PI
The effect of cancer cell produced collagen 1 homotrimers on DDR1 signaling activation by microenvironmental collagen 1 fragments.$174,500
U01 · FY2023 · CA
The Columbia University Digestive and Liver Disease Research Center$1,229,895
P30 · FY2022 · DK · contact PI
Regulation of PDAC metabolism and immunity by collagen and its cleavage products$971,140
U01 · FY2022 · CA
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma$609,144
R01 · FY2022 · CA · contact PI
Protective and fibrosis-independent functions of hepatic stellate cells$532,209
R01 · FY2022 · DK · contact PI
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis$519,971
R01 · FY2022 · DK · contact PI
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC$515,123
R01 · FY2022 · CA · contact PI
The Administrative Core$245,556
P30 · FY2022 · DK · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2021 · DK
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma$621,575
R01 · FY2021 · CA · contact PI
Protective and fibrosis-independent functions of hepatic stellate cells$543,614
R01 · FY2021 · DK · contact PI
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC$535,049
R01 · FY2021 · CA · contact PI
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis$519,971
R01 · FY2021 · DK · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2020 · DK
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma$621,461
R01 · FY2020 · CA · contact PI
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis$519,971
R01 · FY2020 · DK · contact PI
HMGB1 as Link Between Hepatocellular Injury and HCC$443,761
R01 · FY2020 · CA · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2019 · DK
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma$601,544
R01 · FY2019 · CA · contact PI
DAMPs and Their Receptors Link Hepatocyte Death to HSC Activation and Liver Fibrosis$519,971
R01 · FY2019 · DK · contact PI
HMGB1 as Link Between Hepatocellular Injury and HCC$430,447
R01 · FY2019 · CA · contact PI
Hepatic Stellate Cells and Liver Cancer$346,048
R01 · FY2019 · CA · contact PI
TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications$664,138
R01 · FY2018 · DK
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma$634,470
R01 · FY2018 · CA · contact PI
HMGB1 as Link Between Hepatocellular Injury and HCC$443,761
R01 · FY2018 · CA · contact PI
Hepatic Stellate Cells and Liver Cancer$356,751
R01 · FY2018 · CA · contact PI
HMGB1 as Link Between Hepatocellular Injury and HCC$443,761
R01 · FY2017 · CA · contact PI
Targeting DAMPs in Alcoholic Hepatitis$372,541
U01 · FY2017 · AA · contact PI
Hepatic Stellate Cells and Liver Cancer$356,751
R01 · FY2017 · CA · contact PI
HMGB1 as Link Between Hepatocellular Injury and HCC$458,761
R01 · FY2016 · CA · contact PI
Targeting DAMPs in Alcoholic Hepatitis$381,019
U01 · FY2016 · AA · contact PI
Hepatic Stellate Cells and Liver Cancer$358,306
R01 · FY2016 · CA · contact PI
FASEB SRC on Liver Biology: Fundamental Mechanisms and Translational Applications$30,000
R13 · FY2016 · DK · contact PI
Targeting DAMPs in Alcoholic Hepatitis$377,574
U01 · FY2015 · AA · contact PI
Hepatic Stellate Cells and Liver Cancer$370,197
R01 · FY2015 · CA · contact PI
Promotion of Hepatocellular Carcinoma by Myofibroblasts$186,704
U54 · FY2015 · CA · contact PI
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis$396,347
R01 · FY2014 · AA · contact PI
Targeting DAMPs in Alcoholic Hepatitis$385,324
U01 · FY2014 · AA · contact PI
Promotion of Hepatocellular Carcinoma by Myofibroblasts$181,043
U54 · FY2014 · CA · contact PI
Targeting DAMPs in Alcoholic Hepatitis$420,170
U01 · FY2013 · AA · contact PI
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis$379,439
R01 · FY2013 · AA · contact PI
Promotion of Hepatocellular Carcinoma by Myofibroblasts$176,189
U54 · FY2013 · CA · contact PI
Promotion of Hepatocellular Carcinoma by Myofibroblasts$45,158
U54 · FY2013 · CA · contact PI
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis$407,378
R01 · FY2012 · AA · contact PI
Toll-Like Receptor Signaling in Hepatic Fibrogenesis$298,974
R01 · FY2012 · DK · contact PI
Promotion of Hepatocellular Carcinoma by Myofibroblasts$180,345
U54 · FY2012 · CA · contact PI
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis$406,770
R01 · FY2011 · AA · contact PI
Toll-Like Receptor Signaling in Hepatic Fibrogenesis$298,974
R01 · FY2011 · DK · contact PI
The Endocannabinoid System in hepatic Injury and Fibrosis$253,610
R01 · FY2011 · DK · contact PI
Promotion of Hepatocellular Carcinoma by Myofibroblasts$187,504
U54 · FY2011 · CA · contact PI
Role of the Gut Microbiota and TLR4 in Alcoholic Hepatocarcinogenesis$431,663
R01 · FY2010 · AA · contact PI
Toll-Like Receptor Signaling in Hepatic Fibrogenesis$301,994
R01 · FY2010 · DK · contact PI
The Endocannabinoid System in hepatic Injury and Fibrosis$256,172
R01 · FY2010 · DK · contact PI
Prevention of Hepatic Fibrosis by Probiotics$195,525
R21 · FY2010 · AT · contact PI
Toll-Like Receptor Signaling in Hepatic Fibrogenesis$305,044
R01 · FY2009 · DK · contact PI
The Endocannabinoid System in hepatic Injury and Fibrosis$258,759
R01 · FY2009 · DK · contact PI
Prevention of Hepatic Fibrosis by Probiotics$253,000
R21 · FY2009 · AT · contact PI
Toll-Like Receptor Signaling in Hepatic Fibrogenesis$320,294
R01 · FY2008 · DK · contact PI
The Endocannabinoid System in hepatic Injury and Fibrosis$258,759
R01 · FY2008 · DK · contact PI
The Endocannabinoid System in hepatic Injury and Fibrosis$264,040
R01 · FY2007 · DK · contact PI